| Owsley Prescription Center | |
| 820 Ky 11 N, Booneville, Kentucky 41314 | |
| (606) 593-6306 |
| Name | Owsley Prescription Center |
|---|---|
| Organization Name | Jordan Drug Inc |
| Location | 820 Ky 11 N, Booneville, Kentucky 41314 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (606) 593-6306 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute's designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.
"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
Many Sub-Saharan countries have a desperate shortage of surgeons, and to ensure that as many patients as possible can be treated, some operations are carried out by medical professionals who are not specialists in surgery.
› Verified 7 days ago
| NPI Number | 1205862836 |
| Organization Name | JORDAN DRUG, INC. |
| Doing Business As | OWSLEY PRESCRIPTION CENTER |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 820 Hwy 11 North, Booneville, KY 41314 |
| Phone Number | 606-593-6306 |
News Archive
Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute's designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.
"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
Many Sub-Saharan countries have a desperate shortage of surgeons, and to ensure that as many patients as possible can be treated, some operations are carried out by medical professionals who are not specialists in surgery.
› Verified 7 days ago
News Archive
Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute's designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.
"In parts of Africa, only about half of babies born to mothers with HIV receive the HIV prevention drug nevirapine," according to a study published Wednesday, HealthDay News/U.S. News & World Report reports.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
Many Sub-Saharan countries have a desperate shortage of surgeons, and to ensure that as many patients as possible can be treated, some operations are carried out by medical professionals who are not specialists in surgery.
› Verified 7 days ago
Owsley Prescription Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: 820 Ky 11 N, Booneville, Kentucky 41314 Phone: (606) 593-6306 |